跳至主要内容
临床试验/CTRI/2023/07/055027
CTRI/2023/07/055027尚未招募Unknown

tility, Feasibility & Acceptability of a Point of Care Urine Tenofovir Assay to Monitor Treatment & Enhance Adherence to Anti-retroviral Therapy in People Living with HIV

Fogarty International Centre, NIH0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Age > 18 years
  • 2. Viral load >1000
  • 3. PLHIV receiving/restarting a tenofovir-based ART regimen
  • 4. Current ART regimen includes at least one drug with a high genetic barrier to resistance e.g. dolutegravir, protease inhibitors

排除标准

  • 1. Not willing or able to provide informed consent in any of the languages provided
  • 2. Any other clinical condition that in the opinion of an investigator puts the patient at increased risk if participating in the study.

研究者

发起方
Fogarty International Centre, NIH

相似试验